Literature DB >> 25494275

Neprilysin inhibition for heart failure.

John J V McMurray, Milton Packer, Scott D Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25494275     DOI： 10.1056/NEJMc1412654

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.

Authors:  Stuart B Prenner; Sanjiv J Shah; Clyde W Yancy
Journal:  Curr Atheroscler Rep       Date:  2016-08       Impact factor: 5.113

2.  Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients.

Authors:  Niel N Shah; Muhammad U Dogar; Parin N Shah; Sameera Ishtiaq; Shawn Mathew; Pratik Shah; Alia Ishtiaq; Timothy J Vittorio
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-03-13

3.  Inflammation and Circulating Natriuretic Peptide Levels.

Authors:  Hannah Fish-Trotter; Jane F Ferguson; Nirav Patel; Pankaj Arora; Norrina B Allen; Katherine N Bachmann; Lori B Daniels; Muredach P Reilly; Joao A C Lima; Thomas J Wang; Deepak K Gupta
Journal:  Circ Heart Fail       Date:  2020-06-08       Impact factor: 8.790

Review 4.  Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 5.  Sex and Gender Differences in Heart Failure.

Authors:  Vera Regitz-Zagrosek
Journal:  Int J Heart Fail       Date:  2020-04-13

6.  Sex- and Gender-Based Pharmacological Response to Drugs.

Authors:  Franck Mauvais-Jarvis; Heiner K Berthold; Ilaria Campesi; Juan-Jesus Carrero; Santosh Dakal; Flavia Franconi; Ioanna Gouni-Berthold; Mark L Heiman; Alexandra Kautzky-Willer; Sabra L Klein; Anne Murphy; Vera Regitz-Zagrosek; Karen Reue; Joshua B Rubin
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 7.  Is Entresto good for the brain?

Authors:  Nirav Patel; Jason Gluck
Journal:  World J Cardiol       Date:  2017-07-26

8.  Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.

Authors:  Jane A Cannon; Li Shen; Pardeep S Jhund; Søren L Kristensen; Lars Køber; Fabian Chen; Jianjian Gong; Martin P Lefkowitz; Jean L Rouleau; Victor C Shi; Karl Swedberg; Michael R Zile; Scott D Solomon; Milton Packer; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2016-11-20       Impact factor: 15.534

9.  COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.

Authors:  Eftychios Siniorakis; Spyridon Arvanitakis; Ioannis Nikolopoulos; Maximilianos Elkouris
Journal:  mBio       Date:  2020-05-22       Impact factor: 7.867

10.  Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.

Authors:  Tuhina Prasad; Lodi C W Roksnoer; Ping Zhu; Amrisha Verma; Yiming Li; Wendy W Batenburg; René de Vries; A H Jan Danser; Qiuhong Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-12-01       Impact factor: 4.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.